PeterSKozuchMD

Oncology • New York, NY

Gastrointestinal Cancer, Hematologic Oncology

Associate Professor, Medicine, Oncology, Icahn School of Medicine at Mount Sinai

Join to view full profile

Dr. Kozuch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kozuch's full profile

Already have an account?

Office
425 W 59th St
New York, NY 10019
Phone+1 212-523-6705
Is this information wrong?

Education & Training

University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1997 - 2000
Boston University Medical CenterResidency, Internal Medicine, 1994 - 1997
Drexel University College of MedicineClass of 1994

Certifications & Licensure

NY State Medical License 2000 - 2025
MA State Medical License 1997 - 2011
TX State Medical License 1999 - 2000
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2009-2014
New York Magazine: Top Doctors Castle Connolly, 2011

Clinical Trials

Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas Start of enrollment: 2004 Mar 01
Completed
Phase 1
Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer Start of enrollment: 2004 Jun 01
Terminated
Phase 2
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2008 Jun 01
Completed
Phase 3
Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer Start of enrollment: 2004 Jul 01
Completed
Phase 2
Neo-Adjuvant FOLFOX for Rectal Carcinoma Start of enrollment: 2009 Jan 01
Terminated
Phase 2
Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2009 Sep 01
Completed
Phase 2
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
Completed
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol Start of enrollment: 2011 Dec 01
Terminated
Phase 2
METformin With a caRbOhydrate Restricted Diet in Combination With Platinum Based Chemotherapy in Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2013 Sep 01
Join now to see all

Publications & Presentations

PubMed

13 citations
Effects of a Communication Intervention Randomized Controlled Trial to Enable Goals-of-Care Discussions
Nina A. Bickell, Anthony L. Back, Kerin B. Adelson, Jason Gonsky, Natalia N. Egorova, Sofya Pintova, Jenny J. Lin, Peter Kozuch, Emilia Bagiella, Cardinale B. Smith> ;JCO Oncology Practice. 2020 May 6
37 citations
Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial.
Anish B. Parikh, Peter Kozuch, Nicholas Rohs, Daniel Becker, Benjamin Levy> ;Investigational New Drugs. 2017 Sep 22
45 citations
Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysis.
Norihiro Yamaguchi, Takeo Fujii, Shunsuke Aoi, Peter Kozuch, Gabriel N. Hortobagyi, Ronald H. Blum> ;European Journal of Cancer. 2015 Nov 1
Gastric Perforation Following Prophylactic Embolization of Right Gastric and Gastroduodenal Arteries Prior to Selective Internal Radiation Therapy.
Pratik A. Shukla, Jitesh Ahuja, Vineel Kurli, Rajesh I. Patel, Peter Kozuch> ;Cardiovascular and Interventional Radiology. 2015 Jun 13
Colon adenocarcinoma metastatic to the distal extremity.
Tomohiro Funakoshi, Koppany Visnyei, Mariko Yabe, Peter Kozuch> ;Journal of Gastrointestinal Cancer. 2013 Sep 1
2 citations
Phase I study of oxaliplatin in combination with gemcitabine, irinotecan, and 5-fluorouracil/leucovorin (G-FLIE) in patients with metastatic solid tumors including ade...
Adam J. Olszewski, Michael L. Grossbard, Michael S. Chung, Sree Bhavani Chalasani, Stephen Malamud, Tahir Mirzoyev, Peter Kozuch> ;Journal of Gastrointestinal Cancer. 2013 Jun 1
4 citations
Chemotherapy and other supportive modalities in the palliative setting for pancreatic cancer.
Kevin M. Sullivan, Peter Kozuch> ;Cancer Journal. 2012 Nov 1
4 citations
Antiepidermal growth factor receptor monoclonal antibodies: applications in colorectal cancer.
Efat Azizi, Adam Kittai, Peter Kozuch> ;Chemotherapy Research and Practice. 2012 Oct 8
4 citations
Case Report: Long-Term Survival in Patients with Initial Lung-Only Metastasis from Pancreatic Adenocarcinoma
Jonathan I. Gotfried, Peter Kozuch> ;Journal of Gastrointestinal Cancer. 2012 Sep 1
19 citations
Impact of KRAS Mutations on Management of Colorectal Carcinoma
Kevin M. Sullivan, Peter Kozuch> ;Pathology Research International. 2011 Mar 15
39 citations
Colon cancer and the elderly: From screening to treatment in management of GI disease in the elderly
Peter R. Holt, Peter Kozuch, Seetal Mewar> ;Best Practice & Research. Clinical Gastroenterology. 2009 Dec 1
11 citations
Phase II trial of erlotinib and capecitabine for patients with previously untreated metastatic colorectal cancer.
Peter Kozuch, Steve Malamud, Carrie Wasserman, Peter Homel, Takhir Mirzoyev, Michael L. Grossbard> ;Clinical Colorectal Cancer. 2009 Jan 1
53 citations
Treatment of malignant ascites.
Michael Chung, Peter Kozuch> ;Current Treatment Options in Oncology. 2008 Sep 6
40 citations
Bortezomib With or Without Irinotecan in Relapsed or Refractory Colorectal Cancer: Results From a Randomized Phase II Study
Peter Kozuch, Caio Rocha-Lima, Tomislav Dragovich, Howard Hochster, Bert H. O'Neil, Omar Atiq, J. Marc Pipas, David P. Ryan, Heinz-Josef Lenz> ;Journal of Clinical Oncology. 2008 May 10
89 citations
Metastatic Pancreatic Cancer 2008: Is the Glass Less Empty?
Jacqueline Nieto, Michael L. Grossbard, Peter Kozuch> ;The Oncologist. 2008 May 1
20 citations
Pooled efficacy analysis from a phase I-II study of biweekly irinotecan in combination with gemcitabine, 5-fluorouracil, leucovorin and cisplatin in patients with meta...
Anupama Goel, Michael L. Grossbard, Stephen Malamud, Peter Homel, M. Dietrich, Teresa Rodriguez, Takhir Mirzoyev, Peter Kozuch> ;Anti-Cancer Drugs. 2007 Mar 1
61 citations
Non-Hodgkin’s Lymphoma of Mucosa-Associated Lymphoid Tissue
Seth M. Cohen, Magdalena Petryk, Mala Varma, Peter Kozuch, Elizabeth D. Ames, Michael L. Grossbard> ;The Oncologist. 2006 Nov 1
18 citations
Management of adult idiopathic thrombocytopenic purpura.
Ibrahim Nakhoul, Peter Kozuch, Mala Varma> ;Clinical Advances in Hematology & Oncology. 2006 Feb 1
Phase I dose-finding study of biweekly oxaliplatin (E) in combination with gemcitabine (G), 5-fluorouracil (5-FU), leucovorin (LV) and irinotecan (G-FLIE) in patients ...
Olszewski AJ, Malamud S, Grossbard ML, Mirzoyev T, Dietrich M, Thurakal A, Rodriguez T, Kozuch P> ;J. Clin. Oncol.. 2005-06-01
Update of a phase I-II study of biweekly irinotecan in combination with gemcitabine (G), 5FU (F), leucovorin (LV) and cisplatin (G-GLIP) in patients with metastatic pa...
Goel A, Malamud S, Grossbard M, Homel P, Dietrich M, Kozuch P, Mirzoyev T> ;J. Clin. Oncol.. 2005-06-01
7 citations
The horizon of antiangiogenic therapy for colorectal cancer.
Adam J. Olszewski, Michael L. Grossbard, Peter Kozuch> ;Oncology. 2005 Mar 1
Bortezomib ± irinotecan in relapsed/refractory colorectal cancer (CRC): Interim analysis results from phase (ph) 2b study.
Dragovich T, Lenz HJ, Rocha Lima CMS, Kozuch P, Hochster H, O'Neil B, Atiq O, Pipas JM, Kashala O, Schenkein DP> ;J. Clin. Oncol.. 2004-07-15
Biweekly irinotecan in combination with gemcitabine (G), 5-Fluorouracil (5-FU), leucovorin (LV) and cisplatin (G-FLIP) associated with encouraging activity in patients...
Rachamalla R, Malamud S, Grossbard ML, Mathew S, Dietrich M, Kozuch PS> ;J. Clin. Oncol.. 2004-07-15
47 citations
Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.
William P. Daines, Vandana Rajagopalan, Michael L. Grossbard, Peter Kozuch> ;Oncology. 2004 Jul 1
36 citations
Gallbladder and biliary tract carcinoma: A comprehensive update, Part 1.
Vandana Rajagopalan, William P. Daines, Michael L. Grossbard, Peter Kozuch> ;Oncology. 2004 Jun 1
Join now to see all

Press Mentions

New Technology Tests Tumors Inside the Patient to Find Best TreatmentApril 22nd, 2015

Hospital Affiliations

Mount Sinai Beth IsraelNew York, New York
Mount Sinai MorningsideNew York, New York
The Mount Sinai HospitalNew York, New York
Mount Sinai WestNew York, New York
Mount Sinai Hospital of QueensAstoria, New York